Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6994)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2021 (publication date) through Jul 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kawanaka M, Nishino K, Kawamoto H, Haruma K. Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases. World J Gastroenterol 2021; 27(43): 7497-7508 [PMID: 34887645 DOI: 10.3748/wjg.v27.i43.7497] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v27/i43/7497.htm |
| Number | Citing Articles |
| 1 |
Shasha Ma, Lian Zhou, Shutao Lin, Mingna Li, Jing Luo, Lubiao Chen. Noninvasive Models to Assess Liver Inflammation and Fibrosis in Chronic HBV Infected Patients with Normal or Mildly Elevated Alanine Transaminase Levels: Which One Is Most Suitable?. Diagnostics 2024; 14(5): 456 doi: 10.3390/diagnostics14050456
|
| 2 |
Hong-Sheng Yu, Hao Jiang, Ming-Kai Li, Bi-Lan Yang, Abdukyamu Smayi, Jian-Ning Chen, Bin Wu, Yi-Dong Yang. Lowering the threshold of alanine aminotransferase for enhanced identification of significant hepatic injury in chronic hepatitis B patients. World Journal of Gastroenterology 2023; 29(35): 5166-5177 doi: 10.3748/wjg.v29.i35.5166
Abstract(811) |
Core Tip(852) |
Full Article(HTML)(2442)
|
Full Article with Cover (PDF)-2471K(166)
|
Full Article (Word)-894K(49)
|
Audio-1337K(5)
|
Peer-Review Report-228K(109)
|
Answering Reviewers-99K(104)
|
Supplementary Material-264K(103)
|
Full Article (PDF)-1434K(203)
|
Full Article (XML)-113K(96)
|
Times Cited (6)
|
Total Visits (10007)
|
Open
|
| 3 |
Corina Rotãrescu, Mariana Gelinas Martín del Campo, Ion Mãrunțelu. CHRONIC HEPATITIS B VIRUS INFECTION: WHERE WE ARE NOW. Romanian Archives of Microbiology and Immunology 2022; 81(3): 203 doi: 10.54044/RAMI.2022.03.05
|
| 4 |
Katerina Roma, Zahra Dossaji, Lubaba Haque, Tooba Laeeq, Robert G. Gish, Carol Brosgart. Test All for Hepatitis B Virus. Clinics in Liver Disease 2023; 27(4): 997 doi: 10.1016/j.cld.2023.05.009
|
| 5 |
Shuo Li, Zhiguo Li, Hongbo Du, Xiaobin Zao, Da’nan Gan, Xianzhao Yang, Xiaoke Li, Yufeng Xing, Yong’an Ye. Identification of pseudo-immune tolerance for chronic hepatitis B patients: Development and validation of a non-invasive prediction model. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1137738
|
| 6 |
Jian Wang, Li Zhu, Zhiyi Zhang, Shaoqiu Zhang, Yifan Pan, Yuanyuan Li, Fei Cao, Chao Jiang, Tao Fan, Ye Xiong, Jiacheng Liu, Yuxin Chen, Shengxia Yin, Xin Tong, Chuanwu Zhu, Xingxiang Liu, Jie Li, Chao Wu, Rui Huang. Lower HBV DNA level is associated with more severe liver fibrosis in HBeAg-positive chronic hepatitis B with normal alanine transaminase. Virology Journal 2024; 21(1) doi: 10.1186/s12985-024-02368-0
|
| 7 |
Katerina Roma, Toni-Marie Chandler, Zahra Dossaji, Ankoor Patel, Kapil Gupta, Carlos D. Minacapelli, Vinod Rustgi, Robert Gish. A Review of the Systemic Manifestations of Hepatitis B Virus Infection, Hepatitis D Virus, Hepatocellular Carcinoma, and Emerging Therapies. Gastro Hep Advances 2024; 3(2): 276 doi: 10.1016/j.gastha.2023.06.014
|
| 8 |
Mei Huang, Dongyao Wang, Jiao Huang, An-Na Bae, Yun Xia, Xutu Zhao, Mahsa Mortaja, Marjan Azin, Michael R. Collier, Yevgeniy R. Semenov, Jong Ho Park, Shadmehr Demehri. Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens. Nature Communications 2025; 16(1) doi: 10.1038/s41467-025-60894-z
|
| 9 |
Hong Li, Xiao Lin, Lili Liu, Ling Qin, Yanhong Zheng, Xiaohui Liu, Xinhuan Wei, Shan Liang, Yali Liu, Jing Zhang, Xinyue Chen, Zhenhuan Cao. Low Level of Serum Immunoglobulin G Is Beneficial to Clinical Cure Obtained With Pegylated Interferon Therapy in Inactive Surface Antigen Carriers. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.864354
|
| 10 |
Ngai Sze Wong, Denise Pui Chung Chan, Chin Man Poon, Chin Pok Chan, Leonia Hiu Wan Lau, Eng-Kiong Yeoh, Shui Shan Lee. Hepatitis B burden and population immunity in a high endemicity city – a geographically random household epidemiology study for evaluating achievability of elimination. Epidemiology and Infection 2023; 151 doi: 10.1017/S095026882300002X
|
| 11 |
Oludare ‘Sunbo Adewuyi, Muhammad Shakir Balogun, Hirono Otomaru, Alash’le Abimiku, Anthony Agbakizu Ahumibe, Elsie Ilori, Que Anh Luong, Nwando Mba, James Christopher Avong, John Olaide, Oyeladun Okunromade, Adama Ahmad, Afolabi Akinpelu, Chinwe Lucia Ochu, Babatunde Olajumoke, Haruka Abe, Chikwe Ihekweazu, Adetifa Ifedayo, Michiko Toizumi, Hiroyuki Moriuchi, Katsunori Yanagihara, Jide Idris, Lay-Myint Yoshida. Molecular Epidemiology, Drug-Resistant Variants, and Therapeutic Implications of Hepatitis B Virus and Hepatitis D Virus Prevalence in Nigeria: A National Study. Pathogens 2025; 14(1): 101 doi: 10.3390/pathogens14010101
|
| 12 |
Ying Li, Ke-Xing Han, Qian Su, Nan Xu, Qin-Xiu Xie, Yu-Feng Gao. Construction of a Lasso regression-based prediction model for development of cirrhosis in chronic hepatitis B. World Chinese Journal of Digestology 2023; 31(7): 282 doi: 10.11569/wcjd.v31.i7.282
|
| 13 |
Ping Fan, Lan-Qing Li, En-Qiang Chen. The urgency to expand the antiviral indications of general chronic hepatitis B patients. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1165891
|
| 14 |
Chi-Chang Wu. Silicon Nanowires Length and Numbers Dependence on Sensitivity of the Field-Effect Transistor Sensor for Hepatitis B Virus Surface Antigen Detection. Biosensors 2022; 12(2): 115 doi: 10.3390/bios12020115
|
| 15 |
Mequanente Dagnaw, Achenef Asmamaw Muche, Bisrat Misganaw Geremew, Lemma Derseh Gezie. Prevalence and burden of HBV–HIV co-morbidity: a global systematic review and meta-analysis. Frontiers in Public Health 2025; 13 doi: 10.3389/fpubh.2025.1565621
|